Oliver_Triebold

Schellenberg Wittmer advises Bioventure on Series B Financing Round of the Swiss Aphaia Companies

Schellenberg Wittmer has advised Bioventure Club Deal Nine & Co KG on a Series B Financing Round of the Swiss Aphaia Companies, which are clinical stage pharma companies that have developed proprietary treatment methods targeting obesity and associated metabolic diseases.

The corporate/m&a team consisted of partner Oliver Triebold (pictured), Elia Claude Schunck (associate), Laura Roth (trainee lawyer) and also included partner Michael Nordin and senior associate Roland Wild (both tax).

Schellenberg Wittmer advises Bioventure on Series B Financing Round of the Swiss Aphaia Companies

mercedes.galan

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram